Trial Profile
A Study to Evaluate the Safety and Predictors of Efficacy of Omalizumab Therapy in Patients With Severe Asthma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jan 2016
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
- 12 Jan 2016 New trial record